New heart drug tested in real-world chinese patients

NCT ID NCT07361289

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well the drug mavacamten works for Chinese adults with obstructive hypertrophic cardiomyopathy, a condition where the heart muscle is too thick. About 500 people will be followed in regular clinic settings. The main goal is to see if the drug improves blood flow out of the heart.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTROPHIC CARDIOMYOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Local Institution - 0003

    NOT_YET_RECRUITING

    Harbin, Heilongjiang, 150086, China

  • Local Institution - 0005

    NOT_YET_RECRUITING

    Dalian, Liaoning, 116011, China

  • Local Institution - 0007

    NOT_YET_RECRUITING

    Zhengzhou, Henan, 450052, China

  • Local Institution - 0008

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, 100029, China

  • Local Institution - 0009

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510080, China

  • Local Institution - 0010

    NOT_YET_RECRUITING

    Jinan, 250012, China

  • Local Institution - 0013

    WITHDRAWN

    Xi'an, Shan3xi, 710061, China

  • Peking Union Medical College Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100032, China

  • Peking University First Affiliated Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100034, China

  • Suzhou Municipal Hospital

    RECRUITING

    Suzhou, Jiangsu, 215002, China

  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, 310009, China

  • The Second Afilliated Hospital of Hebei Medical University

    RECRUITING

    Jiazhuang, Hebei, 050000, China

  • The Second Hospital of Jilin University

    RECRUITING

    Changchun, Jilin, 130041, China

  • West China Hospital of Sichuan University

    RECRUITING

    Chengdu, Sichuan, 610041, China

  • Zhongshan Hospital Fudan University

    RECRUITING

    Shanghai, 200032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.